Glenn L. Cooper
Voorzitter bij Lascaux Media LLC
Actieve functies van Glenn L. Cooper
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Lascaux Media LLC | Voorzitter | - | - |
Loopbaan van Glenn L. Cooper
Eerdere bekende functies van Glenn L. Cooper
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REPLIGEN CORPORATION | Directeur/Bestuurslid | 25-08-2009 | 13-05-2020 |
| Independent Dir/Board Member | 25-08-2009 | 13-05-2020 | |
| GENTIUM S.P.A. (ADR) | Directeur/Bestuurslid | 10-11-2009 | 27-03-2013 |
| Independent Dir/Board Member | 01-10-2009 | 27-03-2013 | |
| FORTRESS BIOTECH, INC. | Directeur/Bestuurslid | 30-07-2010 | 01-12-2010 |
| Algemeen Directeur | 01-12-2010 | 01-04-2011 | |
| Voorzitter | 01-12-2010 | 02-01-2013 | |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Directeur/Bestuurslid | 01-01-1993 | 16-12-1996 |
| Algemeen Directeur | 16-12-1996 | 01-01-2009 | |
| Voorzitter | 16-12-1996 | 01-01-2009 | |
Progenitor, Inc.
 Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | President | 01-09-1992 | 01-06-1994 |
Lilly Research Center Ltd.
 Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Corporate Officer/Principal | 01-06-1987 | 01-07-1990 |
| Sphinx Pharmaceuticals Corp | Operationeel Directeur | 01-08-1990 | - |
Opleiding van Glenn L. Cooper
| Harvard College | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| Verenigd Koninkrijk | 2 |
| Italië | 2 |
Operationeel
| Director/Board Member | 4 |
| Chairman | 3 |
| Independent Dir/Board Member | 2 |
Sectoraal
| Health Technology | 8 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| FORTRESS BIOTECH, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Health Technology |
| Sphinx Pharmaceuticals Corp | Health Technology |
Lilly Research Center Ltd.
Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Health Technology |
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Gentium SRL manufactures and develops biopharmaceutical products. It offers discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments. The company was founded by Laura Iris Ferro and is headquartered in Villa Guardia, Italy. | Health Technology |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
| Lascaux Media LLC |
- Beurs
- Insiders
- Glenn L. Cooper
- Ervaring
